What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England: a trend analysis in the Clinical Practice Research Datalink

Venexia M Walker; Neil M Davies; Patrick G Kehoe; Richard M Martin

doi:10.7287/peerj.preprints.3238v1

What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England: a trend analysis in the Clinical Practice Research Datalink

Venexia M Walker, Neil M Davies, Patrick G Kehoe, Richard M Martin

Research output: Other contribution

Original language	English
Type	Journal Article
Media of output	Text
DOIs	https://doi.org/10.7287/peerj.preprints.3238v1
Publication status	Published - 8 Sept 2017

Access to Document

10.7287/peerj.preprints.3238v1

Handle.net

Persistent link

Cite this

@misc{d9d472ffef854591be9e4b95ef203898,

title = "What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England: a trend analysis in the Clinical Practice Research Datalink",

author = "Walker, {Venexia M} and Davies, {Neil M} and Kehoe, {Patrick G} and Martin, {Richard M}",

year = "2017",

month = sep,

day = "8",

doi = "10.7287/peerj.preprints.3238v1",

language = "English",

type = "Other",

}

TY - GEN

T1 - What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England: a trend analysis in the Clinical Practice Research Datalink

AU - Walker, Venexia M

AU - Davies, Neil M

AU - Kehoe, Patrick G

AU - Martin, Richard M

PY - 2017/9/8

Y1 - 2017/9/8

UR - https://doi.org/10.7287/peerj.preprints.3238v1

U2 - 10.7287/peerj.preprints.3238v1

DO - 10.7287/peerj.preprints.3238v1

M3 - Other contribution

ER -

What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England: a trend analysis in the Clinical Practice Research Datalink

Access to Document

Handle.net

Other files and links

Cite this